Imaging PR status may help identify tumor response to endocrine therapy

[News]

Research published in the July issue of The Journal of Nuclear Medicine shows imaging progesterone receptor (PR) status also may be able to identify responders and nonresponders to endocrine therapy at an early stage.

More... (http://www.news-medical.net/news/20120703/Imaging-PR-status-may-help-identify-tumor-response-to-endocrine-therapy.aspx)